PHARMA LAB · PL-06-026
Digital Lab Roadmap: Priorities, Integration and Workflow Improvement

In this article
A Digital Lab roadmap should explain which problem will be solved, what conditions must exist and how the outcome will be demonstrated. A list of platforms to buy does not answer those questions. Connecting systems can reduce transcription but also spread unit, version or sample-identity errors faster.
Start with real work: from sample to decision, with people, instruments and records. This proposal organises a laboratory improvement pathway; it does not promise compliance or financial returns from buying software.
Capture processes, records and observed problems
Select a representative workflow and reconstruct it with those who perform and review it. List instruments, systems, spreadsheets, paper forms, transfers and waiting points. For each datum, identify origin, transformations, recipient, owner and retention location. Exceptions matter: what happens to an interrupted sequence, rejected message or change after review?
Separate evidence from assumptions. “There is a lot of transcription” needs clarification; a baseline identifies which fields, for which analyses, in what period and how often. If reliable measurements do not exist, include a collection phase without presenting team estimates as observations.
Define indicators before comparing. Active working time differs from elapsed time between receipt and approval; the rejected-message rate needs a stable denominator. Retain exclusions, unusual cases and changes in sample mix that could affect comparison.
Clarify architecture and record responsibility
Identify which system governs sample identity, method, specification, result and approval. The roles of LIMS, ELN, CDS and SDMS help separate potentially overlapping functions. Two copies are not necessarily redundant: one may be a protected copy or a representation needed for review.
Remove duplicate entry only after showing that the new workflow retains useful controls. If the laboratory uses two method master-data sources, establish who approves versions and how they propagate. Automation without clear ownership also accelerates inconsistency.
Map understandable boundaries and dependencies, including local gateways, external services and historical access. A single platform for everything need not be chosen immediately: first establish where required records reside and who manages them.
Build justified, verifiable priorities
Put applicable requirements and unacceptable risks first. Then assess dependencies, complexity, resources, skills and verifiable benefits. A high financial score cannot offset a missing necessary control. Where evidence is weak, record uncertainty and the work needed to reduce it.
This matrix is a planning example, not a regulatory classification or universal sequence. Agree owners and criteria in the actual setting.
| Problem | Risk | Action | Dependency | Indicator | Owner | Completion |
|---|---|---|---|---|---|---|
| Native data excluded from copying | Incomplete recovery | Define scope and test restore | Inventory and separate environment | Complete-set recovery outcomes | IT and system owner with laboratory | Records and context retrievable against approved criteria |
| Unmanaged interface rejections | Missing or duplicate result | Reconcile and manage exceptions | Defined identifiers and mapping | Open rejections and handling time | Integration owner and QC | Workflow and exceptions verified; operational owner assigned |
| Inconsistent method versions | Decision against wrong reference | Govern master data and distribution | Ownership and approval process | Detected version discrepancies | Method owner | Result-to-version relationship demonstrated |
| Repeated transcription | Avoidable error and work | Pilot a controlled transfer | Reliable source data and defined controls | Manual steps and errors with denominator | Process owner and analysts | Measured benefit without losing controls |
| Scattered review records | Decision without full context | Link evidence and reviewer access | Archive, roles and versions available | Incomplete files and search time | Review owner | Reconstructable set and attributable approvals |
Assign resources and a date for reviewing conditions, not just a purchase date. Management should be able to see blocking dependencies, temporary limitations and decisions required.
Use pilots with entry and exit criteria
A pilot needs defined scope, data, environment and responsibilities. Before entry, check requirements, record protection, competence and exception handling. A test-environment experiment does not authorise production GMP use. Limited operational use requires the relevant assessment and release.
Instrument–LIMS integration verification includes normal flow, invalid data, interruptions and repeated messages according to risk. Exit criteria cover results, deviations, procedures, training and support capacity. Outcomes may be expansion, correction and retesting, or stopping the pathway.
Plan who runs the system after the project: accounts, versions, incidents, backup, periodic review and changes. Training should also check recognition of exceptions and whom to contact. A new workflow is unsustainable if it works only when the project team is present.
Simulated case: a new LIMS does not close existing gaps
A laboratory wants to replace its LIMS to reduce manual work. Its inventory reveals native files from one instrument are excluded from backup and interface rejections have no owner. These are hypothetical case elements, not findings from a real audit.
The team prioritises record protection and rejection handling, promptly assessing impact and interim measures. It develops future LIMS requirements in parallel rather than waiting for purchase to address present risks. Dependencies become explicit: the interface pilot needs reliable sample identity and mapping.
Once conditions are demonstrated, the laboratory tests a limited workflow and measures manual steps, errors and review time with definitions comparable to baseline. No saving percentage is assumed in advance. Only after evaluating outcomes and residual risks does it decide on expansion and plan adjustments.
Measure improvement and revise the roadmap
Compare before and after within the same scope, explaining changes in volumes, methods and personnel. Fewer reported incidents alone do not prove greater reliability; detection may have decreased. Pair efficiency indicators with completeness, recovery and exception-management checks. Record unproven benefits and work requiring correction too.
ICH Q9(R1), adopted in 2023, EMA Corr.2 January 2025, supports decisions informed by knowledge, risk and uncertainty. ICH Q10, 2008, connects objectives, resources, changes and quality-system review. EU GMP Annex 11, January 2011, addresses computerised-system lifecycle and periodic evaluation.
Sources and status checked 2 October 2026. The matrix and case are original implementation proposals: no source mandates this project sequence. A roadmap remains useful when it incorporates learning and keeps decision makers, evidence and limits visible.
Continue exploring
PL-06-025
Laboratory Software and Cloud Suppliers: Qualification and Responsibilities
Qualify the service the laboratory will actually use: from samples and metadata to record retrieval when the contract ends.
Read the articlePL-06-024
Hybrid Laboratory Records: Paper, Electronic Data and Responsibilities
A signature on a printout may not tell the whole analytical story. Define the components, relationships and responsibilities of the hybrid record.
Read the articlePL-06-023
Instrument Software Updates: Impact Assessment and Return to Use
A new version may start correctly while changing the meaning of exported data. Connect each change to risks, tests and release criteria.
Read the article


